Drug intelligence / Profile preview

butaphosphan + cyanocobalamin (Impact Laboratories)

Development stage
Unknown
Lead developer
Sams Pharmaceutical
Modality
Small Molecules
Administration
Intramuscular, Intravenous, Subcutaneous
01

Overview

Butasam is a veterinary injectable formulation containing butaphosphan (an organic phosphorus compound) and cyanocobalamin (vitamin B12). Developed by Sams Pharmaceutical and manufactured by Impact Labs, it is used as a metabolic stimulant, tonic, and roborant in livestock (such as cattle, sheep, goats, swine, and horses) and poultry. Butaphosphan acts as an organic source of phosphorus that participates in energy metabolism, supports liver function, and stimulates fatigued smooth and cardiac muscles. Cyanocobalamin (vitamin B12) is a crucial cofactor in metabolic processes, particularly in gluconeogenesis, protein synthesis, and red blood cell formation. Together, the combination is indicated for the prevention and treatment of metabolic disorders, ketosis, postpartum complications, and general debility or exhaustion in animals.

Brand names
Butasam
Other names
butafosfan + cyanocobalaminbutafosfan + vitamin B12butaphosphan + vitamin B12
02

Targets

MTR (Methionine synthase)MMUT (Methylmalonyl-coenzyme A mutase)

Beyond the preview

Go deeper on butaphosphan + cyanocobalamin (Impact Laboratories).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on butaphosphan + cyanocobalamin (Impact Laboratories).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call